Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota
Foods · 02.04.2026 · 15 (7) · 1206
DOI: 10.3390/foods15071206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foods, online erschienen am 02.04.2026. Verfasst von Min Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi.
Abstract (Originalsprache)
Background
Hyperuricemia (HUA) is associated with excessive uric acid (UA) production, impaired renal excretion, and gut microbial dysbiosis. This study aims to systematically evaluate the alleviating effects of exopolysaccharide (EPS04) derived from Lactiplantibacillus plantarum WLPL04 on HUA.
Methods
The study employed both in vitro HK-2 cells and in vivo animal studies in HUA mice. Key methods included assessing xanthine oxidase (XOD) activity and reactive oxygen species (ROS) production in vitro and measuring serum UA levels, renal function parameters, XOD activity, and gene expression in vivo. Additionally, 16S rRNA sequencing was used to analyze gut microbiota composition.
Results
EPS04 reduced UA production in HK-2 cells by inhibiting XOD activity and downregulating its gene expression while also decreasing XOD-derived ROS. EPS04 significantly lowered serum UA levels and attenuated renal injury in HUA mice. Hepatic XOD expression and activity were downregulated, reducing UA production, while UA excretion was enhanced through upregulation of renal ABCG2 expression. Furthermore, EPS04 increased gut microbiota α-diversity, restored the Bacteroidota/Firmicutes ratio, and enriched beneficial taxa, including Akkermansia and Dubosiella.
Conclusions
EPS04 alleviates HUA through inhibition of XOD activity, upregulation of renal ABCG2 expression, and modulation of gut microbiota, suggesting its potential as a nutraceutical biopolymer for dietary management of HUA and related metabolic disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi
Zitieren
APA
Wei, M., Hu, Y., Li, X., Long, X., Zhang, Z., Tao, X., & Wei, H. (2026). Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota. Foods, 15(7), 1206. https://doi.org/10.3390/foods15071206
Vancouver
Wei M, Hu Y, Li X, Long X, Zhang Z, Tao X, et al. Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota. Foods. 2026;15(7):1206. doi:10.3390/foods15071206
BibTeX
@article{Wei2026,
author = {Wei, Min and Hu, Yingsheng and Li, Xiaoxian and Long, Xingyi and Zhang, Zhihong and Tao, Xueying and Wei, Hua},
title = {Exopolysaccharides from Lactiplantibacillus plantarum WLPL04 Alleviate Hyperuricemia by Regulating Uric Acid Metabolism and Gut Microbiota},
journal = {Foods},
year = {2026},
volume = {15},
number = {7},
pages = {1206},
doi = {10.3390/foods15071206}
}
EUVIMED